Diantha Duvall Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Diantha Duvall.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Diantha Duvall. Diantha Duvall is CHIEF FINANCIAL OFFICER in GENOCEA BIOSCIENCES, INC. ($GNCA) and Chief Accounting Officer in Bioverativ Inc. ($BIVV).
Latest Insider Trading Transactions of Diantha Duvall
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Duvall Diantha | CHIEF FINANCIAL OFF ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Duvall Diantha | CHIEF FINANCIAL OFF ... | Option Exercise | A | 3.01 | 112,500 | 338,625 | 112,500 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Duvall Diantha | CHIEF FINANCIAL OFF ... | Grant | A | 0.00 | 37,500 | 0 | 37,500 | 0 to 37.5 K |
Jun 02 2020 | GNCA | GENOCEA BIOSCIENCE ... | Duvall Diantha | CHIEF FINANCIAL OFF ... | Option Exercise | A | 2.72 | 24,938 | 67,831 | 24,938 | |
Jun 02 2020 | GNCA | GENOCEA BIOSCIENCE ... | Duvall Diantha | CHIEF FINANCIAL OFF ... | Grant | A | 0.00 | 6,623 | 0 | 6,623 | 0 to 6.6 K |
Apr 06 2020 | GNCA | GENOCEA BIOSCIENCE ... | Duvall Diantha | CHIEF FINANCIAL OFF ... | Option Exercise | A | 1.66 | 46,313 | 76,880 | 46,313 | |
Apr 06 2020 | GNCA | GENOCEA BIOSCIENCE ... | Duvall Diantha | CHIEF FINANCIAL OFF ... | Grant | A | 0.00 | 12,299 | 0 | 12,299 | 0 to 12.3 K |
Mar 07 2019 | GNCA | GENOCEA BIOSCIENCE ... | Duvall Diantha | CHIEF FINANCIAL OFF ... | Option Exercise | A | 0.83 | 475,000 | 394,250 | 475,000 | |
Mar 08 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Option Exercise | D | 44.51 | 11,062 | 492,370 | 0 | |
Mar 08 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Option Exercise | D | 52.08 | 7,030 | 366,122 | 0 | |
Mar 08 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Option Exercise | D | 0.00 | 7,273 | 0 | 0 | |
Mar 08 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Option Exercise | D | 0.00 | 2,780 | 0 | 0 | |
Mar 08 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Sell | D | 0.00 | 2,791 | 0 | 0 | 2.8 K to 0 (-100.00 %) |
Mar 05 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Payment of Exercise | F | 104.73 | 105 | 10,997 | 2,791 | 2.9 K to 2.8 K (-3.63 %) |
Feb 26 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Payment of Exercise | F | 104.30 | 168 | 17,522 | 2,896 | 3.1 K to 2.9 K (-5.48 %) |
Feb 15 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Option Exercise | M | 0.00 | 1,390 | 0 | 2,780 | |
Feb 15 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Payment of Exercise | F | 103.52 | 454 | 46,998 | 3,064 | 3.5 K to 3.1 K (-12.91 %) |
Feb 15 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Buy | M | 0.00 | 1,390 | 0 | 3,518 | 2.1 K to 3.5 K (+65.32 %) |
Jun 29 2017 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Sell | S | 60.47 | 818 | 49,464 | 2,128 | 2.9 K to 2.1 K (-27.77 %) |
May 03 2017 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Payment of Exercise | F | 57.48 | 99 | 5,691 | 2,946 | 3 K to 2.9 K (-3.25 %) |
Mar 03 2017 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Payment of Exercise | F | 52.81 | 113 | 5,968 | 3,045 | 3.2 K to 3 K (-3.58 %) |
Feb 16 2017 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Option Exercise | A | 44.51 | 11,043 | 491,524 | 11,043 | |
Feb 16 2017 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Option Exercise | A | 44.51 | 11,043 | 491,524 | 11,043 | |
Feb 16 2017 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Option Exercise | A | 0.00 | 4,170 | 0 | 4,170 | |
Feb 16 2017 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Option Exercise | A | 0.00 | 4,170 | 0 | 4,170 |
Page: 1